Literature DB >> 24519355

Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1.

Roberto Di Fabio1, Christian Marcotulli, Alessandra Tessa, Luca Leonardi, Eugenia Storti, Francesco Pierelli, Filippo M Santorelli, Carlo Casali.   

Abstract

Pathogenic mutations in CYP7B1 account for SPG5, an autosomal recessive hereditary spastic paraplegia characterized by a complex phenotype including visual problems and cerebellar dysfunction. Sensory ataxia is not usually regarded as a typical clinical feature of SPG5. The purpose of this study was to describe six patients showing features of sensory ataxia as the prominent and/or initial symptoms of SPG5. Six patients from three distinct pedigrees (three women, three men; age 49.5 ± 18.2 years), all presenting gait unsteadiness and frequent falls since childhood, underwent clinical and molecular investigations. All showed marked sensory ataxic gait with positive Romberg's sign, as well as severely impaired position and vibration sense. Comparatively minor signs of pyramidal involvement were also detected. In four of the patients, brain MRI showed white matter hyperintensities on T2-weighted images. An already reported homozygous c.889A>G (p.T297A) mutation in SPG5/CYP7B1 was found in five patients from two families, whereas the remaining case harbored the novel c.250_251delC/p.L84Ffs*6 and c.266A>C/p.Y89S variants. Marked and enduring sensory ataxia can be a pivotal sign in SPG5, and expands the phenotypic spectrum associated with mutations in CYP7B1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24519355     DOI: 10.1007/s00415-014-7247-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

Review 1.  Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance.

Authors:  Josef Finsterer; Wolfgang Löscher; Stefan Quasthoff; Julia Wanschitz; Michaela Auer-Grumbach; Giovanni Stevanin
Journal:  J Neurol Sci       Date:  2012-05-01       Impact factor: 3.181

2.  Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations.

Authors:  A Arnoldi; C Crimella; E Tenderini; A Martinuzzi; M G D'Angelo; O Musumeci; A Toscano; M Scarlato; M Fantin; N Bresolin; M T Bassi
Journal:  Clin Genet       Date:  2011-01-31       Impact factor: 4.438

3.  Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation.

Authors:  Marjan Shafaati; Amelia Marutle; Hanna Pettersson; Anita Lövgren-Sandblom; Maria Olin; Irina Pikuleva; Bengt Winblad; Agneta Nordberg; Ingemar Björkhem
Journal:  J Lipid Res       Date:  2011-02-19       Impact factor: 5.922

4.  Interrater reliability of a modified Ashworth scale of muscle spasticity.

Authors:  R W Bohannon; M B Smith
Journal:  Phys Ther       Date:  1987-02

5.  CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5.

Authors:  Cyril Goizet; Amir Boukhris; Alexandra Durr; Christian Beetz; Jeremy Truchetto; Christelle Tesson; Maria Tsaousidou; Sylvie Forlani; Lucie Guyant-Maréchal; Bertrand Fontaine; João Guimarães; Bertrand Isidor; Olivier Chazouillères; Dominique Wendum; Djamel Grid; Françoise Chevy; Patrick F Chinnery; Paula Coutinho; Jean-Philippe Azulay; Imed Feki; Fanny Mochel; Claude Wolf; Chokri Mhiri; Andrew Crosby; Alexis Brice; Giovanni Stevanin
Journal:  Brain       Date:  2009-05-12       Impact factor: 13.501

6.  Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study.

Authors:  Chiara Criscuolo; Alessandro Filla; Giovanni Coppola; Carlo Rinaldi; Rosa Carbone; Stefano Pinto; Qing Wang; Maria Fulvia de Leva; Elena Salvatore; Sandro Banfi; Arturo Brunetti; Mario Quarantelli; Daniel H Geschwind; Sabina Pappatà; Giuseppe De Michele
Journal:  J Neurol       Date:  2009-04-12       Impact factor: 4.849

Review 7.  Central nervous system: cholesterol turnover, brain development and neurodegeneration.

Authors:  John M Dietschy
Journal:  Biol Chem       Date:  2009-04       Impact factor: 3.915

8.  Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration.

Authors:  Maria K Tsaousidou; Karim Ouahchi; Tom T Warner; Yi Yang; Michael A Simpson; Nigel G Laing; Philip A Wilkinson; Ricardo E Madrid; Heema Patel; Faycal Hentati; Michael A Patton; Afif Hentati; Philippa J Lamont; Teepu Siddique; Andrew H Crosby
Journal:  Am J Hum Genet       Date:  2008-01-18       Impact factor: 11.025

Review 9.  Oxysterols in the pathogenesis of major chronic diseases.

Authors:  Giuseppe Poli; Fiorella Biasi; Gabriella Leonarduzzi
Journal:  Redox Biol       Date:  2013-01-31       Impact factor: 11.799

10.  The high prevalence of hereditary spastic paraplegia in Sardinia, insular Italy.

Authors:  Loretta Racis; Alessandra Tessa; Roberto Di Fabio; Eugenia Storti; Virgilio Agnetti; Carlo Casali; Filippo M Santorelli; Maura Pugliatti
Journal:  J Neurol       Date:  2013-10-20       Impact factor: 4.849

View more
  2 in total

1.  Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.

Authors:  Ludger Schöls; Tim W Rattay; Peter Martus; Christoph Meisner; Jonathan Baets; Imma Fischer; Christine Jägle; Matthew J Fraidakis; Andrea Martinuzzi; Jonas Alex Saute; Marina Scarlato; Antonella Antenora; Claudia Stendel; Philip Höflinger; Charles Marques Lourenco; Lisa Abreu; Katrien Smets; Martin Paucar; Tine Deconinck; Dana M Bis; Sarah Wiethoff; Peter Bauer; Alessia Arnoldi; Wilson Marques; Laura Bannach Jardim; Stefan Hauser; Chiara Criscuolo; Alessandro Filla; Stephan Züchner; Maria Teresa Bassi; Thomas Klopstock; Peter De Jonghe; Ingemar Björkhem; Rebecca Schüle
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

2.  A series of Greek children with pure hereditary spastic paraplegia: clinical features and genetic findings.

Authors:  Alexandros A Polymeris; Alessandra Tessa; Katherine Anagnostopoulou; Anna Rubegni; Daniele Galatolo; Argirios Dinopoulos; Artemis D Gika; Sotiris Youroukos; Eleni Skouteli; Filippo M Santorelli; Roser Pons
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.